Uncategorized

Pharma Stocks Aren’t in the Clear, Despite Tariff Exemption—Heard on the Street – WSJ

Posted on Author Tim Hodges Comments Off on Pharma Stocks Aren’t in the Clear, Despite Tariff Exemption—Heard on the Street – WSJ
  1. Pharma Stocks Aren’t in the Clear, Despite Tariff Exemption—Heard on the Street  WSJ
  2. Prescription drugs dodge Trump’s worldwide tariff for now. What to know.  USA Today
  3. Healthcare Stocks Are Steady Amid Tariff Rout. Stay Alert to the Dangers Ahead.  Barron’s
  4. Tariffs will ‘drastically’ impact global pharmaceutical supply  BBC
  5. India’s generic medicines steal the spotlight as US exempts pharma from tariffs  Times of India